Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report

RATIONALE: Pembrolizumab, an immune-checkpoint inhibitor (ICI), has been shown to be effective for treatment-naive patients with non–small cell lung cancer (NSCLC) and high expression of programmed death-ligand 1 (PD-L1). Therefore, treatment regimens containing pembrolizumab have become a standard...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Yamasaki, Masahiro, Funaishi, Kunihiko, Kawamoto, Kazuma, Matsumoto, Yu, Matsumoto, Naoko, Taniwaki, Masaya, Ohashi, Nobuyuki, Hattori, Noboru
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2019
Fag:
5700
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6831270/
https://ncbi.nlm.nih.gov/pubmed/31415404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016834
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker